Optiscan Imaging (ASX:OIL) said it is progressing the development of a digital confocal laser endomicroscopic imaging system for use in robotic surgery in collaboration with the Mayo Clinic, according to a Tuesday Australian bourse filing.
The collaboration leveraged Optiscan's expertise in high-resolution endomicroscopic imaging technology and Mayo Clinic's leadership in robotic surgery and clinical care.
The firms have made advancements as part of their 24-month co-development plan to design an imaging system tailored for robotic-assisted breast cancer surgeries.
Its shares fell 9% in recent trading on Tuesday.